Mon, November 13, 2023

Oren Livnat Maintained (XERS) at Strong Buy with Decreased Target to $5.5 on, Nov 13th, 2023

Oren Livnat of HC Wainwright & Co., Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Decreased Target from $6 to $5.5 on, Nov 13th, 2023.

Oren has made no other calls on XERS in the last 4 months.



There are 2 other peers that have a rating on XERS. Out of the 2 peers that are also analyzing XERS, 0 agree with Oren's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Oren


  • David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $4 on, Friday, November 10th, 2023
  • Robin Garner of "Craig-Hallum" Initiated at Strong Buy and Held Target at $4.5 on, Monday, August 28th, 2023